Literature DB >> 1394035

Serum-ascites albumin concentration gradient and ascites fibronectin in the diagnosis of malignant ascites.

C M Lee1, C S Changchien, W C Shyu, Y F Liaw.   

Abstract

BACKGROUND: The differential diagnosis between malignant and nonmalignant ascites by using laboratory parameters has not been completely achieved so far.
METHODS: The authors studied serum-ascites albumin concentration gradients ([albumin]s - [albumin]a), ascites fibronectin and various parameters in 149 consecutive patients with ascites (including Group 1: 22 patients with intraabdominal malignant lesions; Group 2: 81 patients with chronic liver disease; and Group 3: 46 patients with hepatocellular carcinoma [HCC]).
RESULTS: The concentrations of fibronectin, albumin, protein, lactate dehydrogenase, and carcinoembryonic antigen in ascites were significantly higher in Group 1 than in Group 2 (P < 0.001). By contrast, the [albumin]s - [albumin]a was significantly lower in Group 1 than in Group 2 (P < 0.001). None of these parameters was useful in differentiating the ascites of chronic liver disease from that of HCC. In this study, to differentiate malignant ascites from the ascites caused by liver diseases, [albumin]s - [albumin]a (< 1.5 g/dl) and the fibronectin level in the ascites (> 100 micrograms/ml) provided diagnostic accuracy (96.8% and 95.9%, respectively) as precise as those of the levels of albumin (> 1.6 g/dl), protein (> 2.5 g/dl), and lactate dehydrogenase (> 60 U/l; 97.9%, 96.7%, and 94.8%, respectively) in ascites. These results were better than that of carcinoembryonic antigen level (> 1.5 ng/ml, 80.9%).
CONCLUSIONS: The authors concluded that [albumin]s - [albumin]a offered the best method to survey malignant ascites because of its sensitivity (100%).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1394035     DOI: 10.1002/1097-0142(19921015)70:8<2057::aid-cncr2820700807>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Value of combined detection of AFU and TCH in differential diagnosis between malignant and non-tuberculous benign ascites.

Authors:  Hong Zhang; Feng Li; Qun Wei; Yu-Fei Zhu
Journal:  Med Oncol       Date:  2010-11-02       Impact factor: 3.064

2.  Discrimination between malignant and nonmalignant ascites using serum and ascitic fluid proteins in a multivariate analysis model.

Authors:  M G Alexandrakis; J A Moschandrea; S A Koulocheri; E Kouroumalis; G D Eliopoulos
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

3.  Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications.

Authors:  Angel Mier Hicks; Joanne Chou; Marinela Capanu; Maeve A Lowery; Kenneth H Yu; Eileen M O'Reilly
Journal:  Clin Colorectal Cancer       Date:  2016-05-07       Impact factor: 4.481

4.  New proposal for the serum ascites albumin gradient cut-off value in Chinese ascitic patients.

Authors:  Cai-feng Jiang; Bin Shi; Jian Shi; Zong-li Yuan; Wei-fen Xie
Journal:  Diagn Pathol       Date:  2013-08-23       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.